JCR Pharmaceuticals Co., Ltd.
JCRRF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $84,861 | $171,068 | $171,591 | $270,165 |
| - Cash | $13,196 | $18,756 | $13,278 | $30,733 |
| + Debt | $38,105 | $23,300 | $22,800 | $18,100 |
| Enterprise Value | $109,770 | $175,612 | $181,113 | $257,532 |
| Revenue | $33,072 | $42,871 | $34,343 | $51,082 |
| % Growth | -22.9% | 24.8% | -32.8% | – |
| Gross Profit | $21,738 | $31,251 | $25,457 | $40,621 |
| % Margin | 65.7% | 72.9% | 74.1% | 79.5% |
| EBITDA | -$2,885 | $10,528 | $7,453 | $21,394 |
| % Margin | -8.7% | 24.6% | 21.7% | 41.9% |
| Net Income | -$4,759 | $5,507 | $3,772 | $14,507 |
| % Margin | -14.4% | 12.8% | 11% | 28.4% |
| EPS Diluted | -38.43 | 43.92 | 30.22 | 116.79 |
| % Growth | -187.5% | 45.3% | -74.1% | – |
| Operating Cash Flow | -$5,486 | $9,312 | -$5,500 | $9,289 |
| Capital Expenditures | -$9,888 | -$2,095 | -$8,560 | -$11,333 |
| Free Cash Flow | -$15,374 | $7,217 | -$14,060 | -$2,044 |